AstraZeneca Hit With US Subpoena Over UK Plant
The facility in question, located in the northwest of England, is AstraZeneca's second largest manufacturing site as well as its European drug packing center, according to the company. The company noted it received the request on March 28 in its first-quarter earnings report.
"AstraZeneca is coordinating its response to the subpoena and intends...
To view the full article, register now.